Viewing Study NCT00255502


Ignite Creation Date: 2025-12-25 @ 3:56 AM
Ignite Modification Date: 2025-12-26 @ 2:46 AM
Study NCT ID: NCT00255502
Status: COMPLETED
Last Update Posted: 2020-01-18
First Post: 2005-11-17
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: 307B - Safety, Tolerability and Pharmacokinetics Study of TOPROL-XL® in Hypertensive Pediatric Subjects
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module